SPY362.06-1.61 -0.44%
DIA296.62-2.62 -0.88%
IXIC12,198.74-7.11 -0.06%

RBC Capital Maintains Sector Perform on Biogen, Raises Price Target to $249

RBC Capital maintains Biogen (NASDAQ:BIIB) with a Sector Perform and raises the price target from $244 to $249.

· 11/19/2020 06:42
RBC Capital maintains Biogen (NASDAQ:BIIB) with a Sector Perform and raises the price target from $244 to $249.